These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 36593111)

  • 1. Low dose or very low dose phenylephrine and cyclopentolate microdrops for retinopathy of prematurity eye examinations (The Little Eye Drop Study): a randomised controlled non-inferiority trial.
    Kremer LJ; Medlicott N; Sime MJ; Broadbent R; Edmonds L; Berry MJ; Austin NC; Alsweiler JM; Reith DM
    Arch Dis Child Fetal Neonatal Ed; 2023 Jul; 108(4):380-386. PubMed ID: 36593111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomised controlled pilot trial comparing low dose and very low- dose microdrop administration of phenylephrine and cyclopentolate for retinopathy of prematurity eye examinations in neonates.
    Kremer LJ; Broadbent R; Medlicott N; Sime MJ; McCaffrey F; Reith DM
    Arch Dis Child; 2021 Jun; 106(6):603-608. PubMed ID: 33051215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Survey of Neonatal Nurses on Mydriatic Regimens Used in Neonatal Retinopathy of Prematurity Eye Examinations.
    Kremer L; Reith D; Medlicott NJ; Sime MJ; Edmonds L; Broadbent R
    Am J Perinatol; 2022 Dec; 39(16):1779-1785. PubMed ID: 33784771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety of ocular drugs in pediatrics.
    LaRoche GR
    Ophthalmology; 1987 Feb; 94(2):202-3. PubMed ID: 3574888
    [No Abstract]   [Full Text] [Related]  

  • 5. Transient ileus associated with the use of mydriatics after screening for retinopathy of prematurity in a very low birth weight infant.
    Degirmencioglu H; Oncel MY; Calisici E; Say B; Uras N; Dilmen U
    J Pediatr Ophthalmol Strabismus; 2014 Jul; 51 Online():e44-7. PubMed ID: 25003832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic Absorption of Cyclopentolate and Adverse Events After Retinopathy of Prematurity Exams.
    Mitchell A; Hall RW; Erickson SW; Yates C; Lowery S; Hendrickson H
    Curr Eye Res; 2016 Dec; 41(12):1601-1607. PubMed ID: 27159349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute gastric dilatation complicating the use of mydriatics in a preterm newborn.
    Sarici SU; Yurdakök M; Unal S
    Pediatr Radiol; 2001 Aug; 31(8):581-3. PubMed ID: 11550771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic response to mydriatic eyedrops in neonates: mydriatics in neonates.
    Caputo AR; Schnitzer RE
    J Pediatr Ophthalmol Strabismus; 1978; 15(2):109-22. PubMed ID: 368306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alternative mydriasis techniques for retinopathy of prematurity screening.
    Seliniotaki AK; Prousali E; Lithoxopoulou M; Kokkali S; Ziakas N; Soubasi V; Mataftsi A
    Int Ophthalmol; 2020 Dec; 40(12):3613-3619. PubMed ID: 32772218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pupil dilatation after single and triple doses of mydriatic agent in preterm infants.
    Punyawattanaporn A; Tengtrisorn S; Sangsupawanich P
    J Med Assoc Thai; 2009 Nov; 92(11):1458-62. PubMed ID: 19938737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pain response to mydriatic eyedrops in preterm infants.
    Cohen AM; Cook N; Harris MC; Ying GS; Binenbaum G
    J Perinatol; 2013 Jun; 33(6):462-5. PubMed ID: 23238569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiopulmonary arrest following administration of Cyclomydril eyedrops for outpatient retinopathy of prematurity screening.
    Lee JM; Kodsi SR; Gaffar MA; Rubin SE
    J AAPOS; 2014 Apr; 18(2):183-4. PubMed ID: 24698618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the mydriatic effects of mydrin-P and compound tropicamide in the screening of retinopathy of prematurity.
    Luo S; Wan Z; Yin X; Ye Z; Lu Y
    Eye Sci; 2014 Dec; 29(4):219-22. PubMed ID: 26016074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of dilute drug solutions for routine cycloplegia and mydriasis.
    Brown C; Hanna C
    Am J Ophthalmol; 1978 Dec; 86(6):820-4. PubMed ID: 736080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in intraocular pressure, horizontal pupil diameter, and tear production during the use of topical 1% cyclopentolate in cats and rabbits.
    Kovalcuka L; Nikolajenko M
    Open Vet J; 2020 Apr; 10(1):59-67. PubMed ID: 32426258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of phenylephrine 2.5% with cyclopentolate 0.5% for retinopathy of prematurity screening in 1246 eye examinations.
    Neffendorf JE; Mota PM; Xue K; Hildebrand GD
    Eur J Ophthalmol; 2015; 25(3):249-53. PubMed ID: 25449644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ophthalmic Insert versus Eye Drops for Mydriasis in Neonates: A Randomized Clinical Trial.
    Bremond-Gignac D; Jacqz-Aigrain E; Abdoul H; Daruich A; Beresniak A; Baud O; Alberti C;
    Neonatology; 2019; 115(2):142-148. PubMed ID: 30481790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening premature infants for retinopathy of prematurity in a tertiary hospital in Saudi Arabia.
    Mgharbil E; Raffa LH; Alessa S; Alamri A
    Ann Saudi Med; 2020; 40(2):87-93. PubMed ID: 32241163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eyesight to the Blind-Pharmacotherapy for Retinopathy of Prematurity.
    McPherson C
    Neonatal Netw; 2023 Mar; 42(2):88-95. PubMed ID: 36868806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal failure caused by eyedrops containing phenylephrine in a case of retinopathy of prematurity.
    Shinomiya K; Kajima M; Tajika H; Shiota H; Nakagawa R; Saijyou T
    J Med Invest; 2003 Aug; 50(3-4):203-6. PubMed ID: 13678392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.